CHICAGO — Treating resected brain metastases with cesium-131 tile-based radiation therapy immediately after surgery significantly improved local recurrence and survival compared with standard of care.The findings from a phase 3 randomized trial, presented at ASCO Annual Meeting, showed patients who received the tile therapy had a 93% improvement in surgical bed recurrence and a 41%

CHICAGO — Treating resected brain metastases with cesium-131 tile-based radiation therapy immediately after surgery significantly improved local recurrence and survival compared…

Approach significantly improved local control, and longer survival observed in trial

ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of…